S

Shandong Sinobioway Biomedicine Co Ltd
SZSE:002581

Watchlist Manager
Shandong Sinobioway Biomedicine Co Ltd
SZSE:002581
Watchlist
Price: 13.51 CNY 4.24% Market Closed
Market Cap: 8.9B CNY
Have any thoughts about
Shandong Sinobioway Biomedicine Co Ltd?
Write Note

Shandong Sinobioway Biomedicine Co Ltd
Net Income (Common)

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Shandong Sinobioway Biomedicine Co Ltd
Net Income (Common) Peer Comparison

Comparables:
546
G
9933
600989
600596
A
002597

Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors

Company Net Income (Common) CAGR 3Y CAGR 5Y CAGR 10Y
S
Shandong Sinobioway Biomedicine Co Ltd
SZSE:002581
Net Income (Common)
-ÂĄ308.3m
CAGR 3-Years
N/A
CAGR 5-Years
-30%
CAGR 10-Years
N/A
Fufeng Group Ltd
HKEX:546
Net Income (Common)
ÂĄ2.6B
CAGR 3-Years
47%
CAGR 5-Years
4%
CAGR 10-Years
N/A
G
GHW International
HKEX:9933
Net Income (Common)
ÂĄ2.7m
CAGR 3-Years
N/A
CAGR 5-Years
-48%
CAGR 10-Years
N/A
Ningxia Baofeng Energy Group Co Ltd
SSE:600989
Net Income (Common)
ÂĄ6.7B
CAGR 3-Years
2%
CAGR 5-Years
10%
CAGR 10-Years
N/A
Zhejiang XinAn Chemical Industrial Group Co Ltd
SSE:600596
Net Income (Common)
ÂĄ157.8m
CAGR 3-Years
-51%
CAGR 5-Years
-27%
CAGR 10-Years
-6%
A
Anhui Jinhe Industrial Co Ltd
SZSE:002597
Net Income (Common)
ÂĄ547.9m
CAGR 3-Years
-12%
CAGR 5-Years
-7%
CAGR 10-Years
14%

See Also

What is Shandong Sinobioway Biomedicine Co Ltd's Net Income (Common)?
Net Income (Common)
-308.3m CNY

Based on the financial report for Jun 30, 2024, Shandong Sinobioway Biomedicine Co Ltd's Net Income (Common) amounts to -308.3m CNY.

What is Shandong Sinobioway Biomedicine Co Ltd's Net Income (Common) growth rate?
Net Income (Common) CAGR 5Y
-30%

Over the last year, the Net Income (Common) growth was -234%.

Back to Top